AVCRF
Avricore Health Inc.
Price Chart
Latest Quote
$0.04
-0.01 (-13.98%)
Current Price
| Previous Close | $0.04 |
| Open | $0.04 |
| Day High | $0.04 |
| Day Low | $0.04 |
| Volume | 20,000 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 101.29M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $3.62M |
| EPS (TTM) | $-0.01 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Book/sh | $0.00 |
Financial Ratios
Returns & Margins
Ownership
| Insider Ownership | 9.50% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 12.36 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.04 |
| SMA50 | $0.05 |
| SMA200 | $0.05 |
| RSI | 46.68 |
| ATR | 0.0073 |
| Rel Volume | 0.42 |
Performance History
| Week | -23.98% |
| Month | -11.96% |
| Quarter | -41.67% |
| 6 Months | +11.56% |
| YTD | +11.39% |
| Year | -15.70% |
| 3 Years | -82.34% |
| 5 Years | -76.65% |
| 10 Years | -96.55% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.04 | 20,000 |
| 2026-06-03 | $0.04 | 85,000 |
| 2026-06-02 | $0.04 | 0 |
| 2026-06-01 | $0.04 | 80,000 |
| 2026-05-29 | $0.03 | 36,500 |
| 2026-05-28 | $0.05 | 0 |
| 2026-05-27 | $0.05 | 0 |
| 2026-05-26 | $0.05 | 35,000 |
| 2026-05-22 | $0.03 | 0 |
| 2026-05-21 | $0.03 | 0 |
| 2026-05-20 | $0.03 | 60,000 |
| 2026-05-19 | $0.04 | 100,000 |
| 2026-05-18 | $0.04 | 0 |
| 2026-05-15 | $0.04 | 20,000 |
| 2026-05-14 | $0.04 | 0 |
| 2026-05-13 | $0.04 | 120,000 |
| 2026-05-12 | $0.04 | 120,000 |
| 2026-05-11 | $0.04 | 121,000 |
| 2026-05-08 | $0.04 | 98,968 |
| 2026-05-07 | $0.05 | 50,000 |
| 2026-05-06 | $0.04 | 90,000 |
| 2026-05-05 | $0.04 | 100,000 |
| 2026-05-04 | $0.04 | 70,000 |
About Avricore Health Inc.
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,458,365 | $1,864,031 | $1,129,165 | $92,287 |
| Cost Of Revenue | $2,905,424 | $2,281,751 | $1,311,581 | $92,287 |
| Total Revenue | $4,785,711 | $3,485,147 | $1,768,374 | $122,808 |
| Operating Revenue | $4,785,711 | $3,485,147 | $1,768,374 | $122,808 |
| Expenses | ||||
| Total Expenses | $4,646,363 | $4,172,392 | $2,580,898 | $1,861,591 |
| Rent Expense Supplemental | $27,100 | $18,000 | $16,800 | $12,810 |
| Other Income Expense | $-799,213 | $-11,246 | $-8,369 | $75,314 |
| Net Non Operating Interest Income Expense | $-9,112 | $-2,724 | $2,665 | $-44,663 |
| Total Other Finance Cost | $10,347 | $6,008 | $5,421 | $6,806 |
| Operating Expense | $1,740,939 | $1,890,641 | $1,269,317 | $1,769,304 |
| Other Operating Expenses | $43,089 | $44,545 | $31,888 | $30,738 |
| Selling And Marketing Expense | $0 | $1,035 | $2,961 | $0 |
| General And Administrative Expense | $1,694,713 | $1,842,714 | $1,233,837 | $1,720,582 |
| Interest Expense | - | $0 | $0 | $38,438 |
| Interest Expense Non Operating | - | $0 | $0 | $38,438 |
| Other Non Operating Income Expenses | - | - | - | $75,467 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Net Interest Income | $-9,112 | $-2,724 | $2,665 | $-44,663 |
| Interest Income | $1,235 | $3,284 | $8,086 | $581 |
| Normalized Income | $130,236 | $-689,969 | $-809,859 | $-1,783,446 |
| Net Income From Continuing And Discontinued Operation | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Net Income Common Stockholders | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Net Income | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Net Income Including Noncontrolling Interests | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Net Income Continuous Operations | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Pretax Income | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Special Income Charges | $-794,207 | $-4,594 | $-8,667 | $75,467 |
| Interest Income Non Operating | $1,235 | $3,284 | $8,086 | $581 |
| Operating Income | $139,348 | $-687,245 | $-812,524 | $-1,738,783 |
| Depreciation Amortization Depletion Income Statement | $3,137 | $2,347 | $631 | $17,984 |
| Depreciation And Amortization In Income Statement | $3,137 | $2,347 | $631 | $17,984 |
| Amortization Of Intangibles Income Statement | $3,137 | $2,347 | $631 | $17,984 |
| Gross Profit | $1,880,287 | $1,203,396 | $456,793 | $30,521 |
| Net Income Discontinuous Operations | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Basic EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,388,757 | $-255,932 | $-621,108 | $-1,727,024 |
| Total Unusual Items | $-799,213 | $-11,246 | $-8,369 | $75,314 |
| Total Unusual Items Excluding Goodwill | $-799,213 | $-11,246 | $-8,369 | $75,314 |
| Reconciled Depreciation | $450,196 | $420,067 | $183,047 | $17,984 |
| EBITDA (Bullshit earnings) | $589,544 | $-267,178 | $-629,477 | $-1,651,710 |
| EBIT | $139,348 | $-687,245 | $-812,524 | $-1,669,694 |
| Diluted Average Shares | $100,313,189 | $99,559,459 | $97,859,216 | $92,610,766 |
| Basic Average Shares | $100,313,189 | $99,559,459 | $97,859,216 | $92,610,766 |
| Diluted NI Availto Com Stockholders | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Gain On Sale Of Ppe | $-32,033 | $0 | $0 | - |
| Other Special Charges | $-10,000 | - | - | $-75,467 |
| Write Off | $0 | $4,594 | $8,667 | $0 |
| Impairment Of Capital Assets | $772,174 | $0 | $0 | $0 |
| Gain On Sale Of Security | $-5,006 | $-6,652 | $298 | $-153 |
| Amortization | $3,137 | $2,347 | $631 | $17,984 |
| Selling General And Administration | $1,694,713 | $1,843,749 | $1,236,798 | $1,720,582 |
| Other Gand A | $958,846 | $957,795 | $790,451 | $1,167,197 |
| Insurance And Claims | $90,633 | $92,812 | $60,251 | $44,784 |
| Rent And Landing Fees | $27,100 | $18,000 | $16,800 | $12,810 |
| Salaries And Wages | $618,134 | $774,107 | $366,335 | $495,791 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,908,580 | $1,962,338 | $1,934,229 | $2,165,408 |
| Total Assets | $2,298,544 | $2,538,205 | $2,568,983 | $2,281,393 |
| Total Non Current Assets | $715,588 | $1,764,644 | $1,137,852 | $122,383 |
| Goodwill And Other Intangible Assets | $59,147 | $46,649 | $29,861 | $31,508 |
| Other Intangible Assets | $59,147 | $46,649 | $29,861 | $31,508 |
| Current Assets | $1,582,956 | $773,561 | $1,431,131 | $2,159,010 |
| Prepaid Assets | $20,470 | $38,625 | $30,231 | $54,467 |
| Inventory | $507 | $20,676 | $0 | - |
| Receivables | $419,587 | $427,689 | $770,373 | $91,548 |
| Taxes Receivable | $5,324 | $6,691 | $22,276 | $7,701 |
| Accounts Receivable | $414,263 | $420,998 | $748,097 | $83,847 |
| Cash Cash Equivalents And Short Term Investments | $1,142,392 | $286,571 | $630,527 | $2,012,995 |
| Cash And Cash Equivalents | $1,132,392 | $276,571 | $620,527 | $2,012,995 |
| Debt | ||||
| Total Debt | - | $40,000 | $40,000 | $40,000 |
| Current Debt And Capital Lease Obligation | - | $40,000 | $40,000 | $40,000 |
| Current Debt | - | $40,000 | $40,000 | $40,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $330,817 | $529,218 | $604,893 | $84,477 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $330,817 | $529,218 | $604,893 | $84,477 |
| Payables And Accrued Expenses | $330,817 | $489,218 | $312,893 | $44,477 |
| Payables | $330,817 | $489,218 | $312,893 | $44,477 |
| Total Tax Payable | $74,852 | $60,541 | $51,400 | $0 |
| Accounts Payable | $255,965 | $428,677 | $261,493 | $44,477 |
| Current Deferred Liabilities | - | $0 | $252,000 | $0 |
| Equity | ||||
| Common Stock Equity | $1,967,727 | $2,008,987 | $1,964,090 | $2,196,916 |
| Total Equity Gross Minority Interest | $1,967,727 | $2,008,987 | $1,964,090 | $2,196,916 |
| Stockholders Equity | $1,967,727 | $2,008,987 | $1,964,090 | $2,196,916 |
| Other Equity Interest | $7,067,518 | $6,558,433 | $5,933,708 | $5,794,718 |
| Gains Losses Not Affecting Retained Earnings | $-47 | $0 | $5,933,708 | $5,794,718 |
| Other Equity Adjustments | $-47 | - | - | - |
| Retained Earnings | $-32,404,537 | $-31,735,560 | $-31,034,345 | $-30,216,117 |
| Other | ||||
| Ordinary Shares Number | $101,289,664 | $99,644,664 | $98,619,664 | $97,535,264 |
| Share Issued | $101,289,664 | $99,644,664 | $98,619,664 | $97,535,264 |
| Tangible Book Value | $1,908,580 | $1,962,338 | $1,934,229 | $2,165,408 |
| Invested Capital | $1,967,727 | $2,048,987 | $2,004,090 | $2,236,916 |
| Working Capital | $1,252,139 | $244,343 | $826,238 | $2,074,533 |
| Total Capitalization | $1,967,727 | $2,008,987 | $1,964,090 | $2,196,916 |
| Capital Stock | $27,304,793 | $27,186,114 | $27,064,727 | $26,618,315 |
| Common Stock | $27,304,793 | $27,186,114 | $27,064,727 | $26,618,315 |
| Net PPE | $656,441 | $1,717,995 | $1,107,991 | $90,875 |
| Accumulated Depreciation | $-910,068 | $-602,280 | $-190,712 | $-14,483 |
| Gross PPE | $1,566,509 | $2,320,275 | $1,298,703 | $105,358 |
| Other Properties | $1,566,509 | $2,320,275 | $1,298,703 | $105,358 |
| Other Short Term Investments | $10,000 | $10,000 | $10,000 | $0 |
| Current Deferred Revenue | - | $0 | $252,000 | $0 |
| Current Accrued Expenses | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $799,268 | $-386,456 | $-1,636,348 | $-1,374,518 |
| Operating Activities | ||||
| Operating Cash Flow | $1,004,615 | $660,403 | $-437,832 | $-1,234,154 |
| Cash Flow From Continuing Operating Activities | $1,004,615 | $660,403 | $-437,832 | $-1,234,154 |
| Operating Gains Losses | $22,033 | - | - | - |
| Cash From Discontinued Operating Activities | - | - | - | $0 |
| Investing Activities | ||||
| Capital Expenditure | $-205,347 | $-1,046,859 | $-1,198,516 | $-140,364 |
| Investing Cash Flow | $-205,347 | $-1,046,859 | $-1,208,516 | $-140,364 |
| Cash Flow From Continuing Investing Activities | $-205,347 | $-1,046,859 | $-1,208,516 | $-140,364 |
| Financing Activities | ||||
| Financing Cash Flow | $56,600 | $42,500 | $253,880 | $3,084,798 |
| Cash Flow From Continuing Financing Activities | $56,600 | $42,500 | $253,880 | $3,084,798 |
| Issuance Of Capital Stock | - | $0 | $0 | $2,404,000 |
| Net Common Stock Issuance | - | $0 | $0 | $2,404,000 |
| Common Stock Issuance | - | $0 | $0 | $2,404,000 |
| Net Other Financing Charges | - | - | - | $-98,596 |
| Cash Dividends Paid | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-30,000 | $0 | $0 | $-1,000,000 |
| End Cash Position | $1,132,392 | $276,571 | $620,527 | $2,012,995 |
| Beginning Cash Position | $276,571 | $620,527 | $2,012,995 | $302,715 |
| Effect Of Exchange Rate Changes | $-47 | $0 | - | - |
| Changes In Cash | $855,868 | $-343,956 | $-1,392,468 | $1,710,280 |
| Proceeds From Stock Option Exercised | $86,600 | $42,500 | $253,880 | $1,779,394 |
| Net Issuance Payments Of Debt | $-30,000 | $0 | $0 | $-1,000,000 |
| Net Short Term Debt Issuance | $-30,000 | $0 | $0 | $-1,000,000 |
| Short Term Debt Payments | $-30,000 | $0 | $0 | $-1,000,000 |
| Net Investment Purchase And Sale | $0 | $0 | $-10,000 | $0 |
| Net Intangibles Purchase And Sale | $-24,253 | $-25,288 | $-5,171 | $-35,006 |
| Net PPE Purchase And Sale | $-181,094 | $-1,021,571 | $-1,193,345 | $-105,358 |
| Purchase Of PPE | $-181,094 | $-1,021,571 | $-1,193,345 | $-105,358 |
| Change In Working Capital | $-111,975 | $233,345 | $-142,840 | $-78,235 |
| Change In Payables And Accrued Expense | $-158,401 | $176,325 | $268,416 | $-69,592 |
| Change In Prepaid Assets | $18,155 | $-8,394 | $24,236 | $70,977 |
| Change In Inventory | $20,169 | $-20,676 | $0 | $0 |
| Change In Receivables | $8,102 | $338,090 | $-687,492 | $-79,620 |
| Changes In Account Receivables | $8,102 | $338,090 | $-687,492 | $-79,620 |
| Stock Based Compensation | $541,164 | $703,612 | $331,522 | $495,791 |
| Asset Impairment Charge | $772,174 | $4,594 | $8,667 | $0 |
| Depreciation Amortization Depletion | $450,196 | $420,067 | $183,047 | $17,984 |
| Depreciation And Amortization | $450,196 | $420,067 | $183,047 | $17,984 |
| Amortization Cash Flow | $11,755 | $420,067 | $183,047 | $17,984 |
| Amortization Of Intangibles | $11,755 | $420,067 | $183,047 | $17,984 |
| Depreciation | $438,441 | $411,568 | $176,229 | - |
| Gain Loss On Sale Of PPE | $32,033 | $0 | $0 | - |
| Net Income From Continuing Operations | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 |
| Change In Other Working Capital | - | $-252,000 | $252,000 | - |
| Other Non Cash Items | - | $-1 | - | $38,438 |
| Issuance Of Debt | - | - | $0 | $0 |
| Short Term Debt Issuance | - | - | $0 | $0 |
| Net Long Term Debt Issuance | - | - | $0 | $0 |
| Long Term Debt Payments | - | - | $0 | $0 |
| Purchase Of Investment | - | - | $-10,000 | $0 |
| Interest Paid Cff | - | - | - | $0 |
Fetched: 2026-02-02